Access Pharmaceuticals, Inc.

Polymer therapeutics developer reports status of cash position

Published in Pharma Investments, Ventures and Law Weekly, October 16th, 2005

Access Pharmaceuticals, Inc., (AKC) has cash for operations through September 2005 and believes it should have access to equity and/or credit facilities over the short term to cover cash requirements until the sale of a business unit.

Access has recently made advances on its Standby Equity Distribution Agreement to access such operating cash.

In addition, holders of convertible debentures due September 13, 2005 and September 13, 2008 have agreed to convert the interest ($1,042,000) that is due on September 13, 2005 into equity or delay payment for 1 year.

The company's convertible notes due September 13, 2008 were also extended to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly

Source: Pharma Investments, Ventures and Law Weekly (2005-10-16)

More Articles from Pharma Investments, Ventures and Law Weekly

Aastrom Biosciences, Inc.
Stem cell technology company reports loss of $0.03 per share
Abaris, Inc.
IT company establishes life science division for pharma firms
Aceto Corp.
Pharmaceutical distributor reports income of $0.11 per share
Albany Molecular Research, Inc.
Chemistry-based drug discovery firm adds three people to management team
Alnylam Pharmaceuticals, Inc.
Intellectual property licensed for MicroRNA gene involved in hepatitis C
AmerisourceBergen Corp.
Drug distribution firm completes sale of $900M in senior notes
More from this issue of Pharma Investments, Ventures and Law Weekly

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry